Corporate News     03-Jul-24
Alembic Pharmaceuticals receives USFDA approval (final & tentative) for 11 products

Alembic Pharmaceuticals has received 11 US Food & Drug Administration (USFDA) Product Approvals (Final & Tentative) during the quarter ended 30 June 2024. The products and indication is summarized as under:

Clindamycin Phosphate Topical Gel USP 1% Clindamycin phosphate gel is indicated in the treatment of acne vulgaris.
Diazepam Injection USP, 10mg/2mL (5 mg/mL), Single-Dose Prefilled Syringe Diazepam Injection USP Diazepam is indicated for the management of anxiety disorders or for the shortterm relief of the symptoms of anxiety. 
Selexipag Tablets 1,000mcg and 1,200mcg. Selexipag tablets are indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH.
Binimetinib Tablets 15mg Binimetinib tablet is a kinase inhibitor indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation.
Tretinoin Cream USP, 0.1%, Tretinoin Cream is indicated for topical application in the treatment of acne vulgaris.
Sacubitril and Valsartan Tablets, 24mg/26mg, 49mg/51mg, and 97mg/103 mg. Sacubitril and Valsartan Tablets are indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. It is also indicated for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in paediatric patients aged one year and older.
Methotrexate Tablets USP, 2.5mg Methotrexate Tablets are indicated for the treatment of neoplastic diseases, rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and psoriasis.
Venlafaxine Hydrochloride Extended-Release Capsules USP, 37.5mg, 75mg, and 150mg. Venlafaxine Hydrochloride Extended-Release Capsules are indicated for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder and panic disorder.
Icatibant Injection, 30mg/3 mL (10 mg/mL) Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
Dabigatran Etexilate Capsules, 75mg and 150mg Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult patients; treatment and reduction in the risk of recurrence of deep venous thrombosis and pulmonary embolism in adult patients.
Dabigatran Etexilate Capsules, 110mg Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult patients; treatment and reduction in the risk of recurrence of deep venous thrombosis and pulmonary embolism in adult patients
Doxycycline Capsules, 40mg. Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients.
Bosutinib Tablets, 100mg and 500mg Bosutinib tablets are indicated for the treatment of adult patients with a certain type of leukemia called Philadelphia chromosomepositive chronic myelogenous leukemia. 
Previous News
  Alembic Pharmaceuticals consolidated net profit rises 11.70% in the June 2024 quarter
 ( Results - Announcements 08-Aug-24   15:21 )
  Alembic Pharmaceuticals to convene board meeting
 ( Corporate News - 18-Jan-23   10:51 )
  Alembic Pharmaceuticals receives USFDA final approval for Albendazole Tablets
 ( Corporate News - 05-Sep-24   13:21 )
  Alembic Pharma Q3 PAT slips 29% YoY; R&D spend at Rs 157 crore
 ( Hot Pursuit - 02-Feb-23   10:41 )
  Alembic Pharma receives PAS approval for its sANDA Pregabalin Capsules
 ( Corporate News - 22-Dec-22   13:53 )
  Alembic Pharmaceuticals consolidated net profit declines 39.70% in the December 2021 quarter
 ( Results - Announcements 10-Feb-22   15:37 )
  Alembic Pharmaceuticals Ltd eases for fifth straight session
 ( Hot Pursuit - 22-Feb-22   13:35 )
  Alembic Pharma gets PAS nod from USFDA for pregabalin capsules
 ( Hot Pursuit - 22-Dec-22   14:57 )
  Alembic Pharmaceuticals EGM scheduled
 ( Corporate News - 12-May-22   11:15 )
  Alembic Pharmaceuticals receives USFDA approval for Clomipramine Hydrochloride Capsules
 ( Corporate News - 05-Aug-21   11:59 )
  Board of Alembic Pharmaceuticals appoints director
 ( Corporate News - 10-Feb-22   16:43 )
Other Stories
  Hinduja Global Solutions opens new CX hub in Cape Town, South Africa
  03-Oct-24   10:13
  Anmol India to conduct board meeting
  03-Oct-24   10:07
  KPI Green Energy receives CEIG approval for 5 MW solar power project
  03-Oct-24   10:04
  Navkar Corporation revises board meeting date
  03-Oct-24   09:52
  Paytm deploys card machines across 2 Krishi Mandis in Madhya Pradesh
  03-Oct-24   09:52
  Adani Ports records 14% growth in cargo volumes in September 2024
  03-Oct-24   09:37
  SignatureGlobal India launches new project in Gurugram
  03-Oct-24   09:34
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
  03-Oct-24   09:29
  RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
  03-Oct-24   09:26
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
  03-Oct-24   09:23
Back Top